University of Alabama Birmingham
Oral Lesions as Clinical Markers for Antiretroviral Therapy Failure in HIV Patients
Abstract
dc:description.abstractThe true nature of the association of oral lesions (OL) and gold standards of HIV progression, CD4+ T cell counts (CD4) and HIV-1 RNA viral load (VL), is not completely clear, especially when patients are on antiretroviral therapy (ART). Our aim was to assess the association between OL and virologic failure among HIV/AIDS patients on ART. We conducted a retrospective study of 744 HIV patients who entered care between 2000 and 2006 at the UAB 1917 Clinic. Data was collected for 2 years after enrollment. Prevalence of OL was 35.8%. Oropharyngeal candidiasis (OPC) was the most prevalent OL (74.9%). Among 374 descriptions of OL, 183 represented new cases while 57 were recurrences. The person-visit incidence rate for any OL in our sample was 0.02. Individuals with OL were more likely to have VL =>10,000 when compared to patients with no OL only at baseline and 12 months, (p<0.01 for both times). The difference from time to virologic failure was statistically significant (log-rank 8.10, p<0.01) between patients with baseline OL (mean = 17 months, 95% CI 16, 18) and patients without baseline OL (mean = 19 months, 95% CI 18, 20). Patients who were African-American (HR 1.356; 95% CI = 1.045-0.759), ART experienced (HR 2.298; 95% CI = 1.743-3.030), had a diagnosis of mental disorder (HR 1.410; 95% CI = 1.078-1.843), and had high baseline VL (HR 2.82; 95%CI = 1.661-3.137), were more likely to have a shorter time to virologic failure after the first six months of HIV treatment. Baseline OL was not retained as a predictor in the final model. OL had a moderate PPV for concurrent virologic failure at 6 months (45.5%) and 18 months (33.3%), but a strong PPV at 12 months (80.0%) and 24 months (100.0%). Our results did not fully support the hypothesis of OL as a single accurate clinical marker for virologic failure among ART users. Further studies, are suggested before considering these criteria as a single clinical surrogate for determining treatment failure.
Degree
thesis:*- Level thesis:degree_level
- Dissertation
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Tamí-Maury, Irene M
- Contributors dc:contributor
-
- Craig M Wilson
- Inmaculada Aban
- Pauline Jolly
- Jeffrey Hill
- Sten Vermund
Subjects
dc:subject × 5Identifiers
dc:identifier.*- Repository record dc:identifier
- https://digitalcommons.library.uab.edu/etd-collection/3099